Unitree Prices Shanghai IPO at $9B as Crypto Bets $38B

Unitree Robotics prices at $9B on the Shanghai STAR Market as Hyperliquid perpetuals imply $38B - four times higher - ahead of this week's trading debut.

Lead

Why Is Unitree's IPO 8,000 Times Oversubscribed?

Demand reflects a rare combination in the global robotics sector: genuine profitability, explosive revenue growth, and a hardware lineup - including the Unitree robot dog quadruped and its G1 humanoid series - that has achieved commercial scale precisely when institutional investors are searching for tangible AI infrastructure plays. Retail investors submitted 9.8 million orders worth an estimated 8.1 trillion yuan ($1.2 trillion) during the subscription window, resulting in oversubscription of 8,288 times - a new A-share record. The response signals that demand for listed robotics exposure in China is running well ahead of supply.

Financial Profile: Profitable Where Global Rivals Burn Cash

Unitree reported 2025 revenue of 1.71 billion yuan ($250 million), a 335% increase from 392 million yuan in 2024. Adjusted net profit reached approximately 591 million yuan ($87 million), up 674% year-on-year, with gross margins near 60% and a net margin above 35%. Humanoid robots, which made up just 1.9% of revenue in 2023, accounted for 51.5% of core sales in 2025. The company shipped more than 5,500 humanoid units last year and has sold over 33,000 quadruped robots cumulatively. At the IPO price, shares trade at roughly 219 times 2025 adjusted earnings - a steep multiple that reflects forward assumptions for the category rather than current-year output.

What Do Hyperliquid Perpetuals Reveal About Market Expectations?

Pre-IPO perpetual contracts on Hyperliquid, the decentralized derivatives exchange, traded at approximately $92 to $94 per share in the days before Unitree's debut, implying a market capitalization of about $38 billion - roughly four times the stated $9 billion IPO valuation. The spread points to a sharp divergence between the controlled pricing of a regulated Chinese listing and the unanchored price discovery of global crypto derivatives markets, where participants are betting on a post-debut rally driven by scarcity of listed robotics exposure and sustained institutional demand for AI hardware. Blockchain analytics firm Allium flagged the gap as a potential leverage overhang that could amplify volatility on the first day of Shanghai trading. Bybit separately launched pre-IPO perpetual contracts for Unitree ahead of the official listing, adding further derivatives-market depth to the price signal.

Strategic Context: China's Humanoid Race Goes Public

Unitree's listing arrives as China accelerates its push to dominate global humanoid and quadruped robotics, with state policy directing capital toward domestic manufacturers and away from reliance on foreign supply chains. Founded in 2016, the company built its competitive position on cost-efficient manufacturing and rapid hardware iteration. The Shanghai STAR Market listing - China's high-technology venue analogous to Nasdaq - positions Unitree alongside top-tier domestic chip designers and electric vehicle manufacturers as a benchmark for deep-tech valuations. Tesla (TSLA), whose Optimus humanoid program remains pre-revenue, now faces a direct public-market comparison with a Chinese rival generating $250 million in annual revenue and nearly $90 million in profit. Nvidia (NVDA) and the broader semiconductor ecosystem supplying robotics compute are also being benchmarked against Unitree's margin structure as investors price the full stack.

How Does Unitree Compare to Global Humanoid Peers?

The $9 billion IPO valuation puts Unitree at roughly 36 times 2025 revenue. Loss-making U.S. humanoid startups have attracted private valuations between $25 billion and $40 billion without shipping meaningful commercial volumes. Unitree's 60% gross margin and sustained profitability set a benchmark the broader sector has yet to match at scale, and the listing transforms that private-market comparison into a real-time public reference point. The P/E of 219x at IPO reflects growth expectations consistent with the 335% revenue increase recorded last year, not a valuation premium on a static business.

Outlook

Unitree's debut on the Shanghai STAR Market this week will establish the first transparent public-market price for a scaled, profitable humanoid robot company. The gap between the $9 billion IPO valuation and the $38 billion implied by Hyperliquid perpetuals points to elevated first-day expectations, though leverage concentration in derivatives markets introduces symmetrical downside risk if the opening price disappoints relative to crypto benchmarks. Revenue trajectory and margin structure give Unitree a credible fundamental case independent of speculative dynamics. Where the stock closes on its first day of trading will set valuation anchors for every humanoid robotics company - listed or private - globally.